# Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/prohibition-on-wholesaling-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/dd86fdd5-6650-410b-8062-44da26860675 > FDA guidance document: Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act. Issue date: June 27, 2023. Get complete insights and analysis. --- ## Details - Title: Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2023-06-27 - Comment Close Date: 2023-08-28 - Last Changed: 2023-06-27 - Docket Number: FDA-2023-D-0939 ## Related Documents - [Migraine: Developing Drugs for Preventive Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-preventive-treatment/cd739d7c-f8ed-4a37-b16f-d6f3b9550a94) - [Hospital and Health System Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/hospital-and-health-system-compounding-under-section-503a-of-the-federal-food-drug-and-cosmetic-act-guidance-for-industry/e0535821-7435-45f2-b7a6-0f238fd5d3ed) - [Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act Guidance for Industry: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/current-good-manufacturing-practiceguidance-for-human-drug-compounding-outsourcing-facilities-under-section-503b-of-the-fdc-act-guidance-for-industry-draft-guidance-for-industry/bd9edb09-3aaf-4e80-b088-c65aa8949a54)